[Experience with the use of native anti-rhesus immunoglobulin for prevention of hemolytic disease of the newborn].
D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D011247:Pregnancy
D007136:Immunoglobulins
Dosvid zastosuvannia vitchyznianoho imunohlobulinu antyrezus dlia profilaktyky hemolitychnoï khvoroby novonarodzhenykh.